IFC, a member of the World Bank Group, is providing a US$200m debt financing package to Hikma Pharmaceuticals to help ensure smooth deliveries of medicines across the Middle East and North Africa amid the Covid-19 pandemic. “Hikma is committed to delivering essential medicines to our customers and their patients during this critical time,” said Khalid…
Home Healthcare Markets International Business Jordan: Hikma Pharmaceuticals signs US$200m debt deal with IFC